Clinical Trial Update: Ketone Monitoring Approaches for Diabetic Ketoacidosis Risk Mitigation in People With T1D on Adjunctive SGLT-2 Inhibitors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating ketone monitoring approaches to mitigate diabetic ketoacidosis risk in people with Type 1 diabetes taking adjunctive SG…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• SGLT-2 inhibitors

Snippet

Sponsor: AdventHealth Translational Research Institute | Conditions: Type 1 Diabetes, Type 2 Diabetes | Phase 2 | Status: NOT_YET_RECRUITING